期刊文献+

温阳活血中药复方对冠心病阳虚血瘀证大鼠血小板GPⅡb-Ⅲa的影响 被引量:10

Effect of Warming Yang and Promoting Blood Circulation of Chinese Traditional Medicine Compound Preparation to GPⅡb-Ⅲa on Rat Model Due to Heart Yang Deficiency and Blood Stasis of Coronary Heart Disease
暂未订购
导出
摘要 目的:研究温阳活血中药复方对冠心病阴虚血瘀证大鼠血小板GPⅡb-Ⅲa的影响。方法:建立冠心病阴虚血瘀证大鼠模型;同时观察温阳活血中药复方对冠心病阴虚血瘀证大鼠血小板GPⅡb-Ⅲa的影响。结果:温阳活血中药复方治疗组与模型组比较,能够显著降低血小板膜糖蛋白Ⅱb/Ⅲa(GPⅡb/Ⅲa)分子数,与对照组比较效果尤佳且有明显的量效关系。结论:温阳活血中药复方能够降低GPⅡb/Ⅲa受体的含量,阻断"外-内"信号转导途径,减少GPⅡb/Ⅲa与Fg的结合量,达到抑制血小板聚集的作用。 Objective :To research the effect of warming yang and promoting blood circulation of Chinese traditional medicine compound preparation to GPⅡb-Ⅲa on rat model due to heart Yang deficiency and blood stasis of coronary heart disease. Methods :induce the rat to have CHD due to heart Yang deficiency and blood stasis. Moreover observe the effect of warming yang and promoting blood circulation of Chinese traditional medicine compound preparation to GPⅡb-Ⅲa on rat model due to heart Yang deficiency and blood stasis of coronary heart disease. Results :The group of warming yang and promoting blood circulation of Chinese traditional medicine compound preparation showed the evident difference with the model group,it could decrease the level of the platelet glycoprotein Ⅱb-Ⅲa′s molecule amount, and have a obvi- ous good effect with the comparison group. Conclusion : The warming yang and promoting blood circulation of Chinese traditional medicine compound preparation could decrease the level of GPⅡb-Ⅲa receptor's content, interdiction the “outside - in signalling pathway” ,reduce the combine of GPⅡb/Ⅲa and Fg,constrain the aggregation of platelet.
出处 《中华中医药学刊》 CAS 2007年第11期2270-2271,共2页 Chinese Archives of Traditional Chinese Medicine
基金 国家自然科学基金重大研究项目(90709002) 国家中医药管理局项目(04-05JP13) 辽宁省教育厅资助项目(20040218)
关键词 冠心病阴虚血瘀证 温阳活血中药复方 GPⅡb-Ⅲa coronary heart disease due to heart Yang deficiency and blood stasis warming yang and promoting bloodcirculation of Chinese traditional medicine compound preparation GPⅡb-Ⅲa
  • 相关文献

参考文献2

二级参考文献7

  • 1AntmanF3t, Girgliano RP, Gibaon CM, ET AL. Abciximab facili tates the rate and extent of thrombolysis: Results of the thrombolysis in Myocadical Infarction(TIM1) 14 trial [J]. Cerculation, 1999,99:2720~2732.
  • 2The Abcixlmab in ischemic stroke investigators. Abciximab in acute ischemic stroke. A randomized, double blind, placebo controlled,dose-escalation study[J]. Stroke, 2000,31: 601 ~ 609.
  • 3Belniak LE, Stemasiak Z. Blood platelet activation markers in pl tients with acute cerebral infarction during the earlist stage of the disease evaluation using flow cytometry methods[J] Neurol-Neuro chir-Pol, 2000,34(5) :853~64.
  • 4William GR, Jiang JG. Development of an Ischemia Stroke Survival Score[J]. Stroke, 2000 Oet, 31(10):2414~20.
  • 5Pasche BB, Ouimet H, Francis S, et al. Structural changes in plate let glycoprotein Ⅱ b/ Ⅲ a by plasmin: Determinants and Functional consequences[J]. Blood, 1994,83(2):404~414.
  • 6朱镛连.神经康复学[M].北京:人民军医出版社,2001,5.2-11,20-21.
  • 7韩悦,王兆钺,白霞,阮长耿,朱明清,王爱青.脑梗死、糖尿病患者血小板膜糖蛋白及其与纤维蛋白原结合反应的研究[J].中华血液学杂志,2000,21(3):129-131. 被引量:23

共引文献39

同被引文献196

引证文献10

二级引证文献71

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部